Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NutriVasc
NCT03529019Phase 1Recruiting
- Sponsor
- Boston Medical Center
- Start
- Oct 2018
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in critical limb ischemia (CLI) and Malnutrition, sponsored by Boston Medical Center. Primary endpoints: Change in serum albumin levels at 30 days, Change in prealbumin levels at 30 days and 2 more. Started Oct 2018; status: recruiting.
02
Conditions
critical limb ischemia (CLI)Malnutrition
Beyond the preview
Go deeper on NCT03529019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03529019.